Thomas, Mcnerney & Partners Closes $375 Million Life Science & Medical Technology Fund
Stamford, Minneapolis, San Francisco – September 6, 2006 Thomas, McNerney & Partners, a health care venture capital firm that invests in life science and medical technology companies, today announced the close of its second fund, Thomas, McNerney & Partners II, L.P. with $375 million in limited partner commitments. Consistent with the firm’s inaugural $216 million fund raised in 2002, Thomas, McNerney & Partners II will focus on leading investments in biotechnology, pharmaceutical and medical device companies across all stages of development.